 Prevail Therapeutics PRVL stock is soaring higher on Tuesday following news of a massive 880 million deal with Eli Lilly LLY. The post PRVL Stock: Why Gene Therapy Play Prevail Therapeutics Is Rocketing Higher Tuesday appeared first on InvestorPlace. 